Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas
Article Information
vol. 57 no. 4 1026-1033
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 16, 2007
- Accepted December 19, 2007
- Published in print March 27, 2008.
- Published online ahead of print January 3, 2008.
Article Versions
- Previous version (January 3, 2008 - 13:35).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2008 by the American Diabetes Association
Author Information
- 1Retinal Therapeutic Research Group, Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, Sydney, Australia;
- 2Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China;
- 3Department of Pathology, University of Sydney, Sydney, Australia;
- 4Molecular Biology Facility, Bosch Institute, University of Sydney, Sydney, Australia.
- Address correspondence and reprint requests to Dr. Xinyuan Zhang, Save Sight Institute, Department of Clinical Ophthalmology, Level 2, South Block, Sydney Eye Hospital, Macquarie St, Sydney NSW 2000, Australia. E-mail: xzhang{at}eye.usyd.edu.au.
Statistics from Altmetric.com
Article usage
In this Issue
April 2008, 57(4)
Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas
